[DOI] [PubMed] [Google Scholar] 49.Meineri M., Arellano R., Bryson G., Arzola C., Chen R., Collins P., Denault A., Desjardins G., Fayad A., Funk D., et al
Keywords: GLP-1 receptor agonists, Neuroprotection, Synaptic plasticity, Central nervous system, Neurodegenerative diseases Graphical abstract Introduction GLP-1 receptor agonists (GLP-1RAs) are well-established treatments for type 2 diabetes mellitus (T2DM) and obesity, providing effective glycemic control, weight loss, and cardiovascular benefits [[1], [2], [3]]
The injection volume (which varies by product: Ozempic volumes differ by dose/pen concentration, while Wegovy uses a 0.75 mL single-dose autoinjector) and injection technique can influence local discomfort
Essential Nutrients Fortified with vital vitamins (A, D3, E, C, B-complex) and minerals (calcium, phosphorus, zinc, iron, selenium) to support overall well-being